Skeletal muscle abnormalities in chronic heart failure

Current Heart Failure Reports

Volumn 9, Issue 2, 2012, Pages 128-132

  Georgiadou, Panagiota ^a   Adamopoulos, Stamatis ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cachexia; Chronic heart failure; Management; Pulmonary muscles; Sarcopenia; Skeletal muscle

Indexed keywords

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BREATHING MUSCLE; DISEASE ASSOCIATION; ERGOREFLEX; EXERCISE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; LUNG DISEASE; MORPHOLOGY; MUSCLE MALFORMATION; MUSCLE METABOLISM; MYOPATHY; REFLEX; SKELETAL MUSCLE; TRAINING; CACHEXIA; ENZYMOLOGY; LUNG; MUSCLE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

CACHEXIA; HEART FAILURE; HUMANS; LUNG; MUSCLE, SKELETAL; MUSCULAR DISEASES; RESPIRATORY MUSCLES;

EID: 84864872268     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-012-0090-z     Document Type: Article

References (50)

1. Harrington D, Anker SD, Coats AJ. Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. Eur Heart J. 2001;22:392-9. (Pubitemid 32622444)
2. Adamopoulos S, Coats AJ. Peripheral abnormalities in chronic heart failure. PostgradMed J. 1991;67 Suppl 1:S74-9. discussion S79-80.
3. Nicoletti I, Cicoira M, Zanolla L, et al. Skeletal muscle abnormalities in chronic heart failure patients: relation to exercise capacity and therapeutic implications. Congest Heart Fail. 2003;9:148-54. (Pubitemid 37081528)
4. Steinborn W, Anker S. Cardiac cachexia: pathophysiology and clinical implications. Basic Appl Myol. 2003;13:191-201.
5. Lenk K, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachex Sarcopenia Muscle. 2010;1:9-21.
6. Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B. Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care. 2011;14:15-21.
7. Anker SD, Ponikowski PP, Clark AL, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20:683-93. (Pubitemid 29204354)
8. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112:1756-62. (Pubitemid 41372115)
9. Gruson D, Ahn SA, Ketelslegers JM, Rousseau MF. Increased plasma myostatin in heart failure. Eur J Heart Fail. 2011;13:734-6.
10. Schulze PC, Gielen S, Adams V, et al. Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure. Basic Res Cardiol. 2003;98:267-74. (Pubitemid 36874026)
11. Hambrecht R, Schulze PC, Gielen S, et al. Reduction of insulinlike growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure. J Am Coll Cardiol. 2002;39:1175-81. (Pubitemid 34267422)
12. Latres E, Amini AR, Amini AA, et al. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem. 2005;280:2737-44. (Pubitemid 40189380)
13. Schulze PC, Fang J, Kassik KA, et al. Transgenic overexpression of locally acting IGF-1 inhibits ubiquitin-mediated muscle atrophy in chronic left ventricular dysfunction. Circ Res. 2005;97:418-26. (Pubitemid 41298171)
14. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117:399-412. (Pubitemid 38534545)
15. Du J, Wang X, Miereles C, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest. 2004;113:115-23. (Pubitemid 38541638)
16. Conraads VM, Hoymans VY, Vermeulen T, et al. Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis. Eur J Cardiovasc Prev Rehabil. 2009;16:325-32. This study disputed the findings of skeletal muscle apoptosis in CHF patients and showed a relation between the level of active gene transcription/splicing and exercise performance.
17. Adams V, Jiang H, Yu J, et al. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J Am Coll Cardiol. 1999;33:959-65.
18. Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol. 1993;21:1101-6. (Pubitemid 23106182)
19. Gielen S, Adams V, Möbius-Winkler S, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol. 2003;3(42):861-8. (Pubitemid 37059745)
20. Hambrecht R, Schulze PC, Gielen S, et al. Effects of exercise training on insulin-like growth factor-I expression in the skeletal muscle of non-cachectic patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2005;12:401-6. (Pubitemid 41192174)
21. Scarlett JM, Bowe DD, Zhu X, et al. Genetic and pharmacologic blockade of centralmelanocortin signaling attenuates cardiac cachexia in rodent models of heart failure. J Endocrinol. 2010;206:121-30. This study was the first to reveal a key role for the central melanocortin system in the pathogenesis of cardiac cachexia.
22. Heineke J, Auger-Messier M, Xu J, et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121:419-25. This was the first report on the local production of myostatin within skeletal muscle as a dominant regulator of developmental growth and hypertrophy in adulthood.
23. Anker SD, Coats AJ. How to recover from renaissance? the significance of the results of recover, renaissance, renewal and attach. Int J Cardiol. 2002;86:123-30. (Pubitemid 35284800)
24. Nilsson KR, Duscha BD, Hranitzky PM, Kraus WE. Chronic heart failure and exercise intolerance: the hemodynamic paradox. Curr Cardiol Rev. 2008;4:92-100.
25. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation. 1990;81:518-27. (Pubitemid 20055960)
26. Drexler H, Riede U, Munzel T, et al. Alterations of skeletal muscle in chronic heart failure. Circulation. 1992;85:1751-9.
27. Mancini DM, Coyle E, Coggan A, et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle abnormalities in patients with chronic heart failure. Circulation. 1989;80:1338-46. (Pubitemid 19282524)
28. Ventura-Clapier R, De Sousa E, Veksler V. Metabolic myopathy in heart failure. News Physiol Sci. 2002;17:191-6.
29. Duscha BD, Annex BH, Keteyian SJ, et al. Differences in skeletal muscle between men and women with chronic heart failure. J Appl Physiol. 2001;90:280-6. (Pubitemid 32038529)
30. Tyni-Lenne R, Jansson E, Sylven C. Female-related skeletal muscle phenotype in patients with moderate chronic heart failure before and after dynamic exercise training. Cardiovasc Res. 1999;42:99-103. (Pubitemid 29167074)
31. Kiilavuori K, Näveri H, Salmi T, Härkönen M. The effect of physical training on skeletal muscle in patients with chronic heart failure. Eur J Heart Fail. 2000;2:53-63. (Pubitemid 30202287)
32. Schulze PC, Linke A, Schoene N, et al. Functional and morphological skeletal muscle abnormalities correlate with reduced electromyographic activity in chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2004;11:155-61. (Pubitemid 38591087)
33. Larsen AI, Skadberg Ø, Aarsland T, et al. B-type natriuretic peptide is related to histological skeletal muscle abnormalities in patients with chronic heart failure. Int J Cardiol. 2009;136:358-62.
34. Kindig C, Musch T, Basaraba R, Poole D. Impaired capillary hemodynamics in skeletal muscle of rats in chronic heart failure. J Appl Physiol. 1999;87:652-60. (Pubitemid 29375002)
35. Duscha BD, Annex BH, Green HJ, Pippen AM, Kraus WE. Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol. 2002;39:1170-4. (Pubitemid 34267421)
36. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation. 1991;84:1597-607.
37. Massie BM, Conway M, Yonge R, et al. 31-P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol. 1987;60:309-15. (Pubitemid 17136265)
38. De Sousa E, Lechêne P, Fortin D, N'Guessan B, Belmadani S, Bigard X, Veksler V, Ventura-Clapier R. Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity. Cardiovasc Res. 2002;56:260-8. (Pubitemid 35223496)
39. Hambrecht R, Adams V, Gielen S, et al. Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle. J Am Coll Cardiol. 1999;33:174-9. (Pubitemid 29064089)
40. Schulze PC, Gielen S, Schuler G, Hambrecht R. Chronic heart failure and skeletal muscle catabolism: effects of exercise training. Int J Cardiol. 2002;85:141-9.
41. Brunotte F, Thompson CH, Adamopoulos S, et al. Rat skeletal muscle metabolism in experimental heart failure: effects of physical training. Acta Physiol Scand. 1995;154:439-47.
42. Scott AC, Wensel R, Davos CH, et al. Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure. Eur Heart J. 2004;25:1806-13. (Pubitemid 39330231)
43. Scott AC,Wensel R, Davos CH, et al. Skeletal muscle reflex in heart failure patients: role of hydrogen. Circulation. 2003;107:300-6. (Pubitemid 36135228)
44. Piepoli M, Clark AL, Volterrani M, et al. Contribution of muscle afferents to hemodynamic, autonomic, and ventilatory responses to exercise in patients with chronic heart failure. Circulation. 1996;93:940-52. (Pubitemid 26074831)
45. Ponikowski PP, Chua TP, Francis DP, et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation. 2001;104:2324-30. (Pubitemid 33049516)
46. LeJemtel TH, Maskin CS, Lucido D, Chadwick BJ. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation. 1986;74:245-51. (Pubitemid 16072119)
47. Piepoli MF, Davos C, Francis DP, Coats AJ, ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). Br Med J. 2004;328:189-95.
48. Wong E, Selig S, Hare DL. Respiratory muscle dysfunction and training in chronic heart failure. Heart Lung Circ. 2011;20:289-94.
49. Meyer FJ, Borst MM, Zugck C, et al. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation. 2001;103:2153-8. (Pubitemid 32458324)
50. Winkelmann ER, Chiappa GR, Lima CO, et al. Addition of inspiratory muscle training to aerobic training improves cardiorespiratory responses to exercise in patients with heart failure and inspiratory muscle weakness. Am Heart J. 2009;158:768.e1-7.